Aaron Green

ONMD CEO Aaron Green buys 36,650 shares at $0.57, third ONMD purchase in 11 days; 2 other insiders also bought within past 14 days

Aaron Green, Chief Executive Officer of OneMedNet Corp (ONMD), purchased 36,650 shares at $0.57 on 2026-06-23, bringing his post-transaction holdings to 1,896,375 shares — his third open-market buy at ONMD in 11 days, following prior purchases on 2026-06-12 and 2026-06-15. This purchase occurs with the stock down -85.8% from its 52-week high and -33.6% over the past 30 days. The cluster pattern is notable: 2 other insiders also bought within the past 14 days, making this part of a broader accumulation trend among company insiders. The company carries a quarterly net income of $-2,453,000.00 against revenue of $96,000.00, with a market cap of $32,660,044.20, providing context for the scale of these purchases relative to the company's financial position.

CEO Aaron Green bought 55,622 shares of ONMD in 2 transactions for $30,696.65 at $0.55 avg; stock down 87.2% from 52-week high.

Aaron Green, CEO of OneMedNet Corp, executed 2 separate open-market purchases totaling 55,622 shares for $30,696.65, increasing his holdings by 3.1% from 1,804,103 to 1,859,725 shares. The purchases occurred at $0.56 on 2026-06-12 and $0.54 on 2026-06-15, with a blended average price of $0.55—close to the current price of $0.54. The timing is notable given severe recent price deterioration: the stock is down 87.2% from its 52-week high of $4.22 and down 42.0% over the past 30 days. The company is unprofitable (latest quarter: net income of $-2,453,000.00) despite strong annual revenue growth of 111.4%, indicating operational losses even as top-line expands. The CEO's direct capital commitment at depressed price levels, combined with a $29.4M market cap and significant operational losses, represents material insider accumulation at a juncture of pronounced equity deterioration.